The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Endocrine Testing Market Research Report 2025

Global Endocrine Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1715250

No of Pages : 109

Synopsis

The endocrine system is an integrated network that consists of various glands located throughout the body.

The global Endocrine Testing market was valued at US$ 7664.5 million in 2023 and is anticipated to reach US$ 12270 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.

This report aims to provide a comprehensive presentation of the global market for Endocrine Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Testing.

Report Scope

The Endocrine Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocrine Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endocrine Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List):

  • Abbott Laboratories
  • AdnaGen
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Dako
  • DiaSorin
  • Eiken
  • Fujirebio
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

Segment by Type

  • Tandem Mass Spectrometry
  • Immunoassay

Segment by Application

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centres
  • Other Setting

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tandem Mass Spectrometry
1.2.3 Immunoassay
1.3 Market by Application
1.3.1 Global Endocrine Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Testing Market Perspective (2019-2030)
2.2 Endocrine Testing Growth Trends by Region
2.2.1 Global Endocrine Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Endocrine Testing Historic Market Size by Region (2019-2024)
2.2.3 Endocrine Testing Forecasted Market Size by Region (2025-2030)
2.3 Endocrine Testing Market Dynamics
2.3.1 Endocrine Testing Industry Trends
2.3.2 Endocrine Testing Market Drivers
2.3.3 Endocrine Testing Market Challenges
2.3.4 Endocrine Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Testing Players by Revenue
3.1.1 Global Top Endocrine Testing Players by Revenue (2019-2024)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2019-2024)
3.2 Global Endocrine Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endocrine Testing Revenue
3.4 Global Endocrine Testing Market Concentration Ratio
3.4.1 Global Endocrine Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Testing Revenue in 2023
3.5 Endocrine Testing Key Players Head office and Area Served
3.6 Key Players Endocrine Testing Product Solution and Service
3.7 Date of Enter into Endocrine Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Testing Breakdown Data by Type
4.1 Global Endocrine Testing Historic Market Size by Type (2019-2024)
4.2 Global Endocrine Testing Forecasted Market Size by Type (2025-2030)
5 Endocrine Testing Breakdown Data by Application
5.1 Global Endocrine Testing Historic Market Size by Application (2019-2024)
5.2 Global Endocrine Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Endocrine Testing Market Size (2019-2030)
6.2 North America Endocrine Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Endocrine Testing Market Size by Country (2019-2024)
6.4 North America Endocrine Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Testing Market Size (2019-2030)
7.2 Europe Endocrine Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Endocrine Testing Market Size by Country (2019-2024)
7.4 Europe Endocrine Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Testing Market Size (2019-2030)
8.2 Asia-Pacific Endocrine Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Endocrine Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Endocrine Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Testing Market Size (2019-2030)
9.2 Latin America Endocrine Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Endocrine Testing Market Size by Country (2019-2024)
9.4 Latin America Endocrine Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Testing Market Size (2019-2030)
10.2 Middle East & Africa Endocrine Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Endocrine Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Endocrine Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Endocrine Testing Introduction
11.1.4 Abbott Laboratories Revenue in Endocrine Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 AdnaGen
11.2.1 AdnaGen Company Detail
11.2.2 AdnaGen Business Overview
11.2.3 AdnaGen Endocrine Testing Introduction
11.2.4 AdnaGen Revenue in Endocrine Testing Business (2019-2024)
11.2.5 AdnaGen Recent Development
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Detail
11.3.2 Beckman Coulter/Danaher Business Overview
11.3.3 Beckman Coulter/Danaher Endocrine Testing Introduction
11.3.4 Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2019-2024)
11.3.5 Beckman Coulter/Danaher Recent Development
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Detail
11.4.2 Biomedical Diagnostics Business Overview
11.4.3 Biomedical Diagnostics Endocrine Testing Introduction
11.4.4 Biomedical Diagnostics Revenue in Endocrine Testing Business (2019-2024)
11.4.5 Biomedical Diagnostics Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Detail
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Endocrine Testing Introduction
11.5.4 BioMerieux Revenue in Endocrine Testing Business (2019-2024)
11.5.5 BioMerieux Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Endocrine Testing Introduction
11.6.4 Bio-Rad Revenue in Endocrine Testing Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 Dako
11.7.1 Dako Company Detail
11.7.2 Dako Business Overview
11.7.3 Dako Endocrine Testing Introduction
11.7.4 Dako Revenue in Endocrine Testing Business (2019-2024)
11.7.5 Dako Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Endocrine Testing Introduction
11.8.4 DiaSorin Revenue in Endocrine Testing Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 Eiken
11.9.1 Eiken Company Detail
11.9.2 Eiken Business Overview
11.9.3 Eiken Endocrine Testing Introduction
11.9.4 Eiken Revenue in Endocrine Testing Business (2019-2024)
11.9.5 Eiken Recent Development
11.10 Fujirebio
11.10.1 Fujirebio Company Detail
11.10.2 Fujirebio Business Overview
11.10.3 Fujirebio Endocrine Testing Introduction
11.10.4 Fujirebio Revenue in Endocrine Testing Business (2019-2024)
11.10.5 Fujirebio Recent Development
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Detail
11.11.2 Instrumentation Laboratory Business Overview
11.11.3 Instrumentation Laboratory Endocrine Testing Introduction
11.11.4 Instrumentation Laboratory Revenue in Endocrine Testing Business (2019-2024)
11.11.5 Instrumentation Laboratory Recent Development
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Detail
11.12.2 Kyowa Medex Business Overview
11.12.3 Kyowa Medex Endocrine Testing Introduction
11.12.4 Kyowa Medex Revenue in Endocrine Testing Business (2019-2024)
11.12.5 Kyowa Medex Recent Development
11.13 Matritech
11.13.1 Matritech Company Detail
11.13.2 Matritech Business Overview
11.13.3 Matritech Endocrine Testing Introduction
11.13.4 Matritech Revenue in Endocrine Testing Business (2019-2024)
11.13.5 Matritech Recent Development
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Detail
11.14.2 Ortho-Clinical Diagnostics Business Overview
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Introduction
11.14.4 Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2019-2024)
11.14.5 Ortho-Clinical Diagnostics Recent Development
11.15 Roche
11.15.1 Roche Company Detail
11.15.2 Roche Business Overview
11.15.3 Roche Endocrine Testing Introduction
11.15.4 Roche Revenue in Endocrine Testing Business (2019-2024)
11.15.5 Roche Recent Development
11.16 Siemens
11.16.1 Siemens Company Detail
11.16.2 Siemens Business Overview
11.16.3 Siemens Endocrine Testing Introduction
11.16.4 Siemens Revenue in Endocrine Testing Business (2019-2024)
11.16.5 Siemens Recent Development
11.17 Sysmex
11.17.1 Sysmex Company Detail
11.17.2 Sysmex Business Overview
11.17.3 Sysmex Endocrine Testing Introduction
11.17.4 Sysmex Revenue in Endocrine Testing Business (2019-2024)
11.17.5 Sysmex Recent Development
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Detail
11.18.2 Thermo Fisher Business Overview
11.18.3 Thermo Fisher Endocrine Testing Introduction
11.18.4 Thermo Fisher Revenue in Endocrine Testing Business (2019-2024)
11.18.5 Thermo Fisher Recent Development
11.19 Tosoh
11.19.1 Tosoh Company Detail
11.19.2 Tosoh Business Overview
11.19.3 Tosoh Endocrine Testing Introduction
11.19.4 Tosoh Revenue in Endocrine Testing Business (2019-2024)
11.19.5 Tosoh Recent Development
11.20 Wako
11.20.1 Wako Company Detail
11.20.2 Wako Business Overview
11.20.3 Wako Endocrine Testing Introduction
11.20.4 Wako Revenue in Endocrine Testing Business (2019-2024)
11.20.5 Wako Recent Development
11.21 Wallac/PE
11.21.1 Wallac/PE Company Detail
11.21.2 Wallac/PE Business Overview
11.21.3 Wallac/PE Endocrine Testing Introduction
11.21.4 Wallac/PE Revenue in Endocrine Testing Business (2019-2024)
11.21.5 Wallac/PE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Endocrine Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tandem Mass Spectrometry
Table 3. Key Players of Immunoassay
Table 4. Global Endocrine Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Endocrine Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Endocrine Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Endocrine Testing Market Share by Region (2019-2024)
Table 8. Global Endocrine Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Endocrine Testing Market Share by Region (2025-2030)
Table 10. Endocrine Testing Market Trends
Table 11. Endocrine Testing Market Drivers
Table 12. Endocrine Testing Market Challenges
Table 13. Endocrine Testing Market Restraints
Table 14. Global Endocrine Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Endocrine Testing Market Share by Players (2019-2024)
Table 16. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2023)
Table 17. Ranking of Global Top Endocrine Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Endocrine Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Endocrine Testing Product Solution and Service
Table 21. Date of Enter into Endocrine Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Endocrine Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Endocrine Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Endocrine Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Endocrine Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Endocrine Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Endocrine Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Endocrine Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Endocrine Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Endocrine Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Endocrine Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Endocrine Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Endocrine Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Endocrine Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Endocrine Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Endocrine Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Endocrine Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Endocrine Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Endocrine Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Endocrine Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Endocrine Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Endocrine Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Endocrine Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Endocrine Testing Product
Table 49. Abbott Laboratories Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. AdnaGen Company Detail
Table 52. AdnaGen Business Overview
Table 53. AdnaGen Endocrine Testing Product
Table 54. AdnaGen Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 55. AdnaGen Recent Development
Table 56. Beckman Coulter/Danaher Company Detail
Table 57. Beckman Coulter/Danaher Business Overview
Table 58. Beckman Coulter/Danaher Endocrine Testing Product
Table 59. Beckman Coulter/Danaher Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 60. Beckman Coulter/Danaher Recent Development
Table 61. Biomedical Diagnostics Company Detail
Table 62. Biomedical Diagnostics Business Overview
Table 63. Biomedical Diagnostics Endocrine Testing Product
Table 64. Biomedical Diagnostics Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 65. Biomedical Diagnostics Recent Development
Table 66. BioMerieux Company Detail
Table 67. BioMerieux Business Overview
Table 68. BioMerieux Endocrine Testing Product
Table 69. BioMerieux Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 70. BioMerieux Recent Development
Table 71. Bio-Rad Company Detail
Table 72. Bio-Rad Business Overview
Table 73. Bio-Rad Endocrine Testing Product
Table 74. Bio-Rad Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 75. Bio-Rad Recent Development
Table 76. Dako Company Detail
Table 77. Dako Business Overview
Table 78. Dako Endocrine Testing Product
Table 79. Dako Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 80. Dako Recent Development
Table 81. DiaSorin Company Detail
Table 82. DiaSorin Business Overview
Table 83. DiaSorin Endocrine Testing Product
Table 84. DiaSorin Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 85. DiaSorin Recent Development
Table 86. Eiken Company Detail
Table 87. Eiken Business Overview
Table 88. Eiken Endocrine Testing Product
Table 89. Eiken Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 90. Eiken Recent Development
Table 91. Fujirebio Company Detail
Table 92. Fujirebio Business Overview
Table 93. Fujirebio Endocrine Testing Product
Table 94. Fujirebio Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 95. Fujirebio Recent Development
Table 96. Instrumentation Laboratory Company Detail
Table 97. Instrumentation Laboratory Business Overview
Table 98. Instrumentation Laboratory Endocrine Testing Product
Table 99. Instrumentation Laboratory Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 100. Instrumentation Laboratory Recent Development
Table 101. Kyowa Medex Company Detail
Table 102. Kyowa Medex Business Overview
Table 103. Kyowa Medex Endocrine Testing Product
Table 104. Kyowa Medex Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 105. Kyowa Medex Recent Development
Table 106. Matritech Company Detail
Table 107. Matritech Business Overview
Table 108. Matritech Endocrine Testing Product
Table 109. Matritech Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 110. Matritech Recent Development
Table 111. Ortho-Clinical Diagnostics Company Detail
Table 112. Ortho-Clinical Diagnostics Business Overview
Table 113. Ortho-Clinical Diagnostics Endocrine Testing Product
Table 114. Ortho-Clinical Diagnostics Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 115. Ortho-Clinical Diagnostics Recent Development
Table 116. Roche Company Detail
Table 117. Roche Business Overview
Table 118. Roche Endocrine Testing Product
Table 119. Roche Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 120. Roche Recent Development
Table 121. Siemens Company Detail
Table 122. Siemens Business Overview
Table 123. Siemens Endocrine Testing Product
Table 124. Siemens Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 125. Siemens Recent Development
Table 126. Sysmex Company Detail
Table 127. Sysmex Business Overview
Table 128. Sysmex Endocrine Testing Product
Table 129. Sysmex Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 130. Sysmex Recent Development
Table 131. Thermo Fisher Company Detail
Table 132. Thermo Fisher Business Overview
Table 133. Thermo Fisher Endocrine Testing Product
Table 134. Thermo Fisher Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 135. Thermo Fisher Recent Development
Table 136. Tosoh Company Detail
Table 137. Tosoh Business Overview
Table 138. Tosoh Endocrine Testing Product
Table 139. Tosoh Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 140. Tosoh Recent Development
Table 141. Wako Company Detail
Table 142. Wako Business Overview
Table 143. Wako Endocrine Testing Product
Table 144. Wako Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 145. Wako Recent Development
Table 146. Wallac/PE Company Detail
Table 147. Wallac/PE Business Overview
Table 148. Wallac/PE Endocrine Testing Product
Table 149. Wallac/PE Revenue in Endocrine Testing Business (2019-2024) & (US$ Million)
Table 150. Wallac/PE Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endocrine Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Endocrine Testing Market Share by Type: 2023 VS 2030
Figure 3. Tandem Mass Spectrometry Features
Figure 4. Immunoassay Features
Figure 5. Global Endocrine Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Endocrine Testing Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Commercial Laboratories Case Studies
Figure 9. Ambulatory Care Centres Case Studies
Figure 10. Other Setting Case Studies
Figure 11. Endocrine Testing Report Years Considered
Figure 12. Global Endocrine Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Endocrine Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Endocrine Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Endocrine Testing Market Share by Players in 2023
Figure 16. Global Top Endocrine Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Endocrine Testing Revenue in 2023
Figure 18. North America Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Endocrine Testing Market Share by Country (2019-2030)
Figure 20. United States Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Endocrine Testing Market Share by Country (2019-2030)
Figure 24. Germany Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Endocrine Testing Market Share by Region (2019-2030)
Figure 32. China Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Endocrine Testing Market Share by Country (2019-2030)
Figure 40. Mexico Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Endocrine Testing Market Share by Country (2019-2030)
Figure 44. Turkey Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Endocrine Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 47. AdnaGen Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 48. Beckman Coulter/Danaher Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 49. Biomedical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 50. BioMerieux Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 51. Bio-Rad Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 52. Dako Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 53. DiaSorin Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 54. Eiken Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 55. Fujirebio Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 56. Instrumentation Laboratory Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 57. Kyowa Medex Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 58. Matritech Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 59. Ortho-Clinical Diagnostics Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 60. Roche Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 61. Siemens Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 62. Sysmex Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 63. Thermo Fisher Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 64. Tosoh Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 65. Wako Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 66. Wallac/PE Revenue Growth Rate in Endocrine Testing Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’